NEOMYCIN SULFATE | A060365 | BRISTOL MYERS SQUIBB CO
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Sparhawk Laboratories, Inc FDA-2006-P-0332 Sparhawk Laboratories, Inc. filed this petition on June 19, 2006, to change the dosage form of Neomycin from soluble powder to liquid under NADA 11-315, with supporting data submitted as Neomycin Liquid under ANADA 200-379, and requested categorical exclusion from environmental assessment requiremen | Other | 2009-03-30 | Granted | Sparhawk Laboratories |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.